In vivo Radiosensitization Effect of H DAC Inhibitor, SK-7041 on RIF-1 Cell Line |
Chie, Eui-Kyu
(Department of Radiation Oncology, Seoul National University College of Medicine)
Shin, Jin-Hee (Department of Radiation Oncology, Seoul National University College of Medicine) Kim, In-Ah (Department of Radiation Oncology, Seoul National University College of Medicine) Kim, Il-Han (Department of Radiation Oncology, Seoul National University College of Medicine) |
1 | Park JH, Jung Y, Kim TY, et al. Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation. Clin Cancer Res 2004;10:5271-5281 DOI ScienceOn |
2 | Purrucker JC, Fricke A, Ong MF, Rube C, Rube CE, Mahlknecht U. HDAC inhibition radiosensitizes human normal tissue cells and reduces DNA Double-Strand Break repair capacity. Oncol Rep 2010;23:263-269 |
3 | Coyle TE, Bair AK, Stein C, Vajpayee N, Mehdi S, Wright J. Acute leukemia associated with valproic acid treatment: a novel mechanism for leukemogenesis? Am J Hematol 2005;78:256-260 DOI ScienceOn |
4 | Camphausen K, Scott T, Sproull M, Tofilon PJ. Enhancement of xenograft tumor radiosensitivity by the histone deacetylase inhibitor MS-275 and correlation with histone hyperacetylation. Clin Cancer Res 2004;10:6066-6071 DOI ScienceOn |
5 | Chung YL, Wang AJ, Yao LF. Antitumor histone deacetylase inhibitors suppress cutaneous radiation syndrome: implications for increasing therapeutic gain in cancer radiotherapy. Mol Cancer Ther 2004;3:317-325 DOI ScienceOn |
6 | Baylin SB, Ohm JE. Epigenetic gene silencing in cancer: a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 2006;6:107-116 DOI ScienceOn |
7 | Paoluzzi L, Figg WD. Histone deacetylase Inhibitors are potent radiation protectants. Cancer Biol Ther 2004;3:612-613 DOI ScienceOn |
8 | Lee KW, Kim JH, Park JH, et al. Antitumor activity of SK-7041, a novel histone deacetylase inhibitor, in human lung and breast cancer cells. Anticancer Res 2006;26:3429-3438 |
9 | Ryu JK, Lee WJ, Lee KH, et al. SK-7041, a new histone deacetylase inhibitor, induces G2-M cell cycle arrest and apoptosis in pancreatic cancer cell lines. Cancer Lett 2006;237:143-154 DOI ScienceOn |
10 | Kim BK. Radiosensitizing effect and mechanisms of action of a novel HDAC inhibitor, SK-7041 [dissertation]. Seoul: Seoul National University, 2007 |
11 | Esteller M. Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. Br J Cancer 2006;94:179-183 DOI ScienceOn |
12 | Kim DK, Lee JY, Kim JS, et al. Synthesis and biological evaluation of 3-(4-substituted-phenyl)-N-hydroxy-2-propenamides, a new class of histone deacetylase inhibitors. J Med Chem 2003:46:5745-5751 DOI ScienceOn |
13 | Kim JH, Shin JH, Chie EK, et al. Trichostatin A, a histone deacetylase inhibitor, potentiated cytotoxic effect of inonizing radiation in human head and neck cancer cell lines. J Korean Soc Ther Radiol Oncol 2004;22:138-144 과학기술학회마을 |
14 | Kim JH, Shin JH, Kim IH. Susceptibility and radiosensitization of human glioblastoma cells to trichostatin A, a histone deacetylase inhibitor. Int J Radiat Oncol Biol Phys 2004;59:1174-1180 DOI ScienceOn |
15 | Kim IA, Kim JH, Shin JH, et al. A histone deacetylase inhibitor, trichostatin A, enhances radiosensitivity by abrogating G2/M arrest in human carcinoma cells. Cancer Res Treat 2005;37:122-128 DOI ScienceOn |
16 | Kim IA, Kim JH, Shin JH, et al. Leptomycin B increases radiosensitization by trichostatin A in HeLa cells. J Korean Soc Ther Radiol Oncol 2005;23:116-122 과학기술학회마을 |
17 | Camphausen K, Tofilon PJ. Inhibition of histone deacetylation: a strategy for tumor radiosensitization. J Clin Oncol 2007;25:4051-4056 DOI ScienceOn |
18 | De Schutter H, Nuyts S. Radiosensitizing potential of epigenetic anticancer drugs. Anticancer Agents Med Chem 2009:9:99-108 DOI ScienceOn |